HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noushin Farnoud Selected Research

Noushin Farnoud Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 01/2018
4Primary Myelofibrosis (Myelosclerosis)
01/2023 - 01/2018
4Polycythemia Vera
12/2022 - 01/2019
3Blast Crisis (Blast Phase)
01/2022 - 10/2020
3Leukemia
01/2022 - 10/2016
2Essential Thrombocythemia
12/2022 - 10/2019
2Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2019 - 01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Fibrosis (Cirrhosis)
08/2019
1Splenomegaly
08/2019
1Disease Resistance
01/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2016
1Intellectual Disability (Idiocy)
09/2006

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
01/2023 - 01/2018
3ruxolitinibIBA
10/2020 - 01/2019
2InterferonsIBA
12/2022 - 10/2019
2Hydroxyurea (Hydrea)FDA LinkGeneric
12/2022 - 10/2019
2RG7388IBA
11/2020 - 01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Topoisomerase II InhibitorsIBA
11/2020
1PlatinumIBA
11/2020
1DecitabineFDA Link
10/2020
1peginterferon alfa-2a (Pegasys)FDA Link
10/2019
1Aurora Kinase AIBA
08/2019
1MLN 8237IBA
08/2019
1enasidenibIBA
01/2018
1Janus Kinase InhibitorsIBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2016
1Proteins (Proteins, Gene)FDA Link
10/2016
1ChromatinIBA
10/2016
1OligonucleotidesIBA
09/2006

Therapy/Procedure

8Therapeutics
12/2022 - 01/2018
1Induction Chemotherapy
01/2022
1Transplantation
01/2019
1Cell Transplantation
01/2019